NANO — Nanobiotix SA Cashflow Statement
0.000.00%
Last trade - 00:00- €135.58m
- €134.80m
- -€11.61m
Annual cashflow statement for Nanobiotix SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -33.6 | -47 | -57 | -39.7 | -68.1 |
| Depreciation | |||||
| Non-Cash Items | -1.47 | 4.03 | 16.1 | 15.8 | 32.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.76 | 11.5 | 2.3 | 9.91 | 14.2 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -27.5 | -29.9 | -37.1 | -12.5 | -19.6 |
| Capital Expenditures | -0.107 | -0.233 | -0.093 | -0.337 | -0.848 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.005 | -0.009 | 0.231 | -0.012 | -0.107 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.112 | -0.242 | 0.138 | -0.349 | -0.955 |
| Financing Cash Flow Items | -11.3 | -4.27 | -4.56 | -12.7 | -4.05 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 112 | -5.18 | -5.65 | 46.8 | -5.13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 84.1 | -35.2 | -42.5 | 33.9 | -25.5 |